These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 27019627)
21. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
22. Phenotypic and microRNA characterization of the neglected CD24+ cell population in MCF-7 breast cancer 3-dimensional spheroid culture. Boo L; Yeap SK; Ali NM; Ho WY; Ky H; Satharasinghe DA; Liew WC; Tan SW; Wang ML; Cheong SK; Ong HK J Chin Med Assoc; 2020 Jan; 83(1):67-76. PubMed ID: 31904742 [TBL] [Abstract][Full Text] [Related]
23. miR-145 overexpression triggers alteration of the whole transcriptome and inhibits breast cancer development. Ye P; Shi Y; An N; Zhou Q; Guo J; Long X Biomed Pharmacother; 2018 Apr; 100():72-82. PubMed ID: 29425746 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC). Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271 [TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer. Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954 [TBL] [Abstract][Full Text] [Related]
27. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice. Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149 [TBL] [Abstract][Full Text] [Related]
29. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Hu Y; Xu K; Yagüe E Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794 [TBL] [Abstract][Full Text] [Related]
30. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer. Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453 [TBL] [Abstract][Full Text] [Related]
31. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
32. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro. Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485 [TBL] [Abstract][Full Text] [Related]
33. Polyphenol-Enriched Blueberry Preparation Controls Breast Cancer Stem Cells by Targeting FOXO1 and miR-145. Mallet JF; Shahbazi R; Alsadi N; Matar C Molecules; 2021 Jul; 26(14):. PubMed ID: 34299605 [TBL] [Abstract][Full Text] [Related]
34. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin. Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353 [TBL] [Abstract][Full Text] [Related]
35. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956 [TBL] [Abstract][Full Text] [Related]
36. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1. Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Bitarte N; Bandres E; Boni V; Zarate R; Rodriguez J; Gonzalez-Huarriz M; Lopez I; Javier Sola J; Alonso MM; Fortes P; Garcia-Foncillas J Stem Cells; 2011 Nov; 29(11):1661-71. PubMed ID: 21948564 [TBL] [Abstract][Full Text] [Related]
38. Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines. Guo J; He K; Zeng H; Shi Y; Ye P; Zhou Q; Pan Z; Long X Oncol Lett; 2019 Apr; 17(4):3765-3776. PubMed ID: 30930984 [TBL] [Abstract][Full Text] [Related]
39. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479 [TBL] [Abstract][Full Text] [Related]
40. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. Golestaneh AF; Atashi A; Langroudi L; Shafiee A; Ghaemi N; Soleimani M Cell Biochem Funct; 2012 Jul; 30(5):411-8. PubMed ID: 22374783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]